Integrated BioPharmaINBP 
$0.22-4.35%24h
-4.35%24h
Global rank33865
Market cap$6.59M
Change 7d-4.35%
YTD Performance-12.00%
SP500 benchmarkUnderperform
P/E-193.83
P/S0.13
Revenue$50.67M
Earnings-$34.00K
Dividend yield-
Main Sector
Consumer Defensive
Category
Market capitalization of Integrated BioPharma (INBP)
As of November 2024, Integrated BioPharma has a market cap of $6.59M. This makes Integrated BioPharma the world's 33865th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Integrated BioPharma from 1996 to 2024
-
Value:-
Market cap history of Integrated BioPharma from 1996 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $6.89M | -8.00% |
| 2023 | $7.49M | -28.57% |
| 2022 | $10.48M | -66.35% |
| 2021 | $31.15M | 40.54% |
| 2020 | $22.16M | 196.00% |
| 2019 | $7.49M | 66.67% |
| 2018 | $4.49M | -16.67% |
| 2017 | $5.39M | -21.74% |
| 2016 | $6.89M | 130.00% |
| 2015 | $2.99M | 11.11% |
| 2014 | $2.70M | -52.63% |
| 2013 | $5.69M | 18.75% |
| 2012 | $4.79M | 433.33% |
| 2011 | $898.49K | -66.67% |
| 2010 | $2.70M | -25.00% |
| 2009 | $3.59M | -42.86% |
| 2008 | $6.29M | -92.02% |
| 2007 | $78.77M | -61.88% |
| 2006 | $206.65M | 67.88% |
| 2005 | $123.09M | -40.43% |
| 2004 | $206.65M | -43.67% |
| 2003 | $366.88M | 2816.67% |
| 2002 | $12.58M | 82.61% |
| 2001 | $6.89M | -77.00% |
| 2000 | $29.95M | 60.00% |
| 1999 | $18.72M | -16.67% |
| 1998 | $22.46M | 50.00% |
| 1997 | $14.97M | -92.00% |
| 1996 | $187.19M | - |
INBP Market Cap Today is $6.59M -4.35% - 21 Nov 2024
View largest stocks by market cap 
